Home・Stock List・Zealand Pharma A-S

Zealand Pharma A-S

Closed

297 1.02

Buy Sell

Overview

Share price change

24h

Current

Min

283.4

Max

294

Key metrics
By Trading Economics
Income	-15M -394M
Sales	-35M 34M
P/E Sector Avg	3.172 50.958
EPS	-5.58
Profit margin	-1,158.824
Employees	544
EBITDA	-26M -529M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+25.15% upside

Dividends
By Acuity
Next Earnings	13 Aug 2026

Market Stats
By TradingEconomics
Market Cap	-1.3B 20B
Previous open	295.98
Previous close	297

Zealand Pharma A-S Chart

Past performance is not a reliable indicator of future results.

Related News

29 Jun 2026, 23:56 UTC

Willis Towers Watson PLC shares declined slightly in after-market trading, reflecting routine price fluctuations. The asset remains above its 20-day moving average.

29 Jun 2026, 23:56 UTC

Skyworks Solutions Inc. shares are lower in after-market hours, continuing to trade below their 20-day moving average amid a trend of lower closes.

29 Jun 2026, 23:52 UTC

Japan's Industrial Production Expected to Rise 1.1% in May 2026 Amidst Market Volatility and Uncertainties

29 Jun 2026, 23:52 UTC

Japan's May unemployment rate holds steady at 2.5%, aligning with market expectations and reflecting labor market stability.

29 Jun 2026, 23:52 UTC

Brazil's S&P Global Services PMI release on July 3, 2026, expected to show continued challenges in the services sector amid stagnant demand and rising inflation pressures.

29 Jun 2026, 23:52 UTC

U.S. Initial Jobless Claims Expected at 220,000 Amid Positive Labor Market Sentiment Ahead of July Release

29 Jun 2026, 23:52 UTC

U.S. JOLTs Job Openings Report Set for June 30, Forecasting 7.3 Million Positions Amid Optimistic Employment Growth Sentiment

29 Jun 2026, 23:52 UTC

ECB Forum on Central Banking to Address Interest Rate Policies Amid Cautious Investor Sentiment and Geopolitical Tensions

29 Jun 2026, 23:52 UTC

Social Media

Microsoft shares are higher in after-market trading amid strong interest in cloud and AI infrastructure, despite a legal challenge over copyright infringement.

29 Jun 2026, 23:51 UTC

U.S. equity markets show mixed performance amid cautious optimism from U.S.-Iran talks and anticipation of key economic data, including Non-Farm Payrolls.

29 Jun 2026, 23:51 UTC

Global equity markets show mixed performance as Asian indices rise on easing U.S.-Iran tensions, while European stocks decline ahead of key U.S. economic data releases.

29 Jun 2026, 23:51 UTC

European equity markets show mixed results amid geopolitical tensions and economic uncertainty, with improved Euro Area consumer confidence but declining UK mortgage approvals.

29 Jun 2026, 23:51 UTC

Asia equity markets mixed as U.S.-Iran talks boost sentiment, while European indices decline ahead of central bank discussions.

29 Jun 2026, 23:51 UTC

ETF Constituents

The Consumer Staples Select Sector SPDR Fund is higher in after-market trading, with Costco and Walmart among the top contributors to performance.

29 Jun 2026, 23:51 UTC

Cognizant Technology Solutions shares are higher in after-market trading, reflecting positive sentiment from broader technology gains and recent geopolitical developments.

29 Jun 2026, 23:46 UTC

United States Copper Index Fund shows modest gains in after-market trading. The asset fluctuated between a low of -1.07% and a high of 0.59%.

29 Jun 2026, 23:46 UTC

T-Mobile US Inc. shares traded roughly flat in after-market hours, influenced by broader gains in technology stocks and a recovery in major averages.

29 Jun 2026, 23:41 UTC

Correlated Moves

ETF Constituents

During after-market hours, GDX traded near unchanged, reflecting contributions from Newmont Corporation and Wheaton Precious Metals amid a modest rise in gold prices.

29 Jun 2026, 23:41 UTC

iShares TIPS Bond ETF is lower in after-market hours, continuing a decline since Monday's close amid unusual volatility, without any specific news identified.

29 Jun 2026, 23:41 UTC

Kraft Heinz Co shares are lower in after-market hours. No specific news was identified to explain the decline, despite recent higher closes.

29 Jun 2026, 23:41 UTC

Macro News

Correlated Moves

Bitcoin is trading higher amid eased geopolitical tensions between the U.S. and Iran, reflecting positive sentiment in the cryptocurrency market.

29 Jun 2026, 23:31 UTC

ETF Constituents

iShares MSCI Germany ETF declines after market close, impacted by EUR/USD rates and SAP's performance. The asset remains below its 20-day moving average.

29 Jun 2026, 23:31 UTC

Verisk Analytics Inc shares are higher in after-market hours, reaching near the upper end of their one-month range amid cautious market optimism and geopolitical developments.

29 Jun 2026, 23:31 UTC

Japan's Household Spending Report on July 6, 2026, Anticipated Amid Strong Retail Growth and Currency Concerns.

29 Jun 2026, 23:31 UTC

Japan's Household Spending Report Set for July 6, Amidst Strong Retail Sales and Yen Decline Concerns.

29 Jun 2026, 23:31 UTC

Shares of Fiserv Inc. are higher in after-market trading, despite earlier declines. Investor sentiment is influenced by geopolitical developments and cautious optimism in the market.

29 Jun 2026, 23:31 UTC

Macro News

ETF Constituents

Energy Select Sector SPDR Fund rises after Gulfport Energy's $83 million acquisition and a decline in the U.S. Dollar Index during after-market trading.

29 Jun 2026, 23:31 UTC

News

Social Media

Comcast shares are higher in after-market trading amid reports of a potential expansion into video games and plans for AI-focused data centers.

29 Jun 2026, 23:26 UTC

MercadoLibre Inc. shares are trading higher in after-market hours, influenced by cautious optimism surrounding U.S.-Iran negotiations and broader market sentiment.

29 Jun 2026, 23:26 UTC

Correlated Moves

ETF Constituents

Digital Realty Trust's decline led to little change in VNQ after-hours.

Peer Comparison

Price change

Zealand Pharma A-S Forecast

Price Target

By TipRanks

25.15% upside

12 Months Forecast

Average 270.582 DKK 25.15%

High 270.568 DKK

Low 270.568 DKK

Based on 1 Wall Street analysts offering 12 month price targets forZealand Pharma A-S - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

1 ratings

Buy

Hold

Sell

Based on 1 analysts giving stock ratings to Zealand Pharma A-S - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Zealand Pharma A-S

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.